Vaccinex Inc (VCNX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
On February 14, 2024, Vaccinex, Inc. implemented a 1-for-14 reverse stock split, consolidating every fourteen shares into one. This adjustment, effective on February 19, aims to maintain proportional shareholder interests, adjusting equity incentive plans accordingly, without changing stock par value or shareholders’ voting rights. The stock will trade under the same symbol “VCNX” with a new CUSIP number starting February 20 on Nasdaq. Despite these changes, the company cautions that forward-looking statements involve risks and actual results may vary.
For further insights into VCNX stock, check out TipRanks’ Stock Analysis page.